<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180107038251N6</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-03-04</date_registration>
      <primary_sponsor>Arak University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of progressive muscle relaxation technique and inhalation aromatherapy with Lavender essence on anxiety and vital signs</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of progressive muscle relaxation technique and inhalation aromatherapy with Lavender essence on anxiety and vital signs in patients undergoing spinal anesthesia</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-02-05</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>120</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/61113</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: Patients will be selected by convenient sampling methods and then randomly assigned to intervention with  aroma A ,massage B, and control C groups by permutation blocks  with six blocks ABCABC,AABBCC,AACCBB,CCABAB, Blinding description: Participants will be divided into three groups: intervention 1, intervention 2, and the control group. One group is called A and the other groups are called B and C. Before and after the intervention, information is collected by the outcome assessor  who is unaware of the classification. Data analysis is also performed by a person who is unaware of groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Anxiety in patients undergoing Spinal anesthesia.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In progressive muscle relaxation technique group, 30 minutes before spinal anesthesia the patient's vital signs will be monitored and the demographic and Spielberger questionnaires will be filled in, then, patients will be asked to first contract the muscles of the feet to the muscles of the face and then relax. At the same time, patients will breathe deeply during relaxation. The selected position for gradual relaxation will be lying down. after surgery, the vital signs will be checked and the Spielberger question will be filled in. Intervention 2: Intervention group: 30 minutes before spinal anesthesia, the patient's vital signs will be monitored and recorded and the demographic questionnaire and Spielberger questionnaire will be filled in, then the pads saturated with 2 drops of 2% lavender essence, produced in Baricha Essence of Kashan Company, will be attached to the front of the chest. It will be inhaled for 20 minutes. Then, after surgery, the vital signs will be checked and the Spielberger question will be filled in. Intervention 3: Control group: Patients in the control group will receive routine care during this period and only research tools will be filled in by them.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Nazanin</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>سردشت، دانشگاه علوم پزشکی اراک، دانشکده پیراپزشکی</address>
        <city>Arak</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3819693345</zip>
        <telephone>+98 86 3417 3507</telephone>
        <email>nazaninamini69@yahoo.com</email>
        <affiliation>Arak University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr Hessamedin Modir</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Arak University of Medical Sciences, Sardasht</address>
        <city>Arak</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3819693345</zip>
        <telephone>+98 86 3417 3507</telephone>
        <email>modir.he@gmail.com</email>
        <affiliation>Arak University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Alertness and ability to speak
Patients aged over 18 years and under 65 years.
Negative  history of known mental illness
Negative  history of allergies or respiratory diseases
Negative history of using anxiolytics, opioids, or strong analgesics
Absence of severe pain due to underlying disease(cancer)
No contraindications for frequent muscle contractions and expansions
Ability to read, write and understand Persian</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Sudden pain not related to surgery
Convulsion and any life-threatening emergencies
History of mental illness
being allergic to lavender inhalation
Treatment with anti-depressants drugs
Patients with cognitive, visual, or speech impairments
Patients undergoing  oncology surgery  and major surgery
Opioid, anti-anxiety drugs, muscle relaxants or any interfering drug requirement during spinal anesthesia
Patients undergoing pilonidal sinus surgery or any surgery Which requires a prone position</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F41.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Anxiety disorder, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In progressive muscle relaxation technique group, 30 minutes before spinal anesthesia the patient's vital signs will be monitored and the demographic and Spielberger questionnaires will be filled in, then, patients will be asked to first contract the muscles of the feet to the muscles of the face and then relax. At the same time, patients will breathe deeply during relaxation. The selected position for gradual relaxation will be lying down. after surgery, the vital signs will be checked and the Spielberger question will be filled in.</i_keyword>
      <i_keyword>Intervention group: 30 minutes before spinal anesthesia, the patient's vital signs will be monitored and recorded and the demographic questionnaire and Spielberger questionnaire will be filled in, then the pads saturated with 2 drops of 2% lavender essence, produced in Baricha Essence of Kashan Company, will be attached to the front of the chest. It will be inhaled for 20 minutes. Then, after surgery, the vital signs will be checked and the Spielberger question will be filled in.</i_keyword>
      <i_keyword>Control group: Patients in the control group will receive routine care during this period and only research tools will be filled in by them.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Anxiety. Timepoint: 30 minutes before spinal anesthesia and after surgery. Method of measurement: Spielberger Standard Questionnaire.</prim_outcome>
      <prim_outcome>Respiratory rate. Timepoint: 30 minutes before spinal anesthesia and after surgery. Method of measurement: Chest observation.</prim_outcome>
      <prim_outcome>Pulse rate. Timepoint: 30 minutes before spinal anesthesia and after surgery. Method of measurement: Pulse oximetry.</prim_outcome>
      <prim_outcome>Temperature. Timepoint: 30 minutes before spinal anesthesia and after surgery. Method of measurement: Thermometer.</prim_outcome>
      <prim_outcome>Blood pressure. Timepoint: 30 minutes before spinal anesthesia and after surgery. Method of measurement: Blood pressure monitor.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Satisfaction level. Timepoint: From the beginning of anesthesia to the end of surgery. Method of measurement: 5-point Likert scale 5-point Likert scale.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Arak University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-12-05</approval_date>
        <contact_name>Arak University of Medical Sciences</contact_name>
        <contact_address>Arak University of Medical Sciences, Railroad Street, Alamol Huda Street Arak Markazi Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
